EMILY IPPOLITO: Open Payments
NPI 1780294520 · MASSAPEQUA PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$813 in 25 payments from 11 companies in 2025. Trend: 2023 $377 · 2024 $618 · 2025 $813
Food & beverage: $813
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 5 | $211 |
| Indivior Inc. | 4 | $198 |
| Janssen Pharmaceuticals, Inc | 3 | $93 |
| Alkermes, Inc. | 3 | $75 |
| Axsome Therapeutics, Inc. | 3 | $73 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $67 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
Products named: BRIXADI, SUBLOCADE, SPRAVATO, VIVITROL, Auvelity, CAPLYTA, ABILIFY ASIMTUFII, XIFAXAN.
Industry payments across NY — which companies pay providers there.
